Investors & Media

Company Overview

LyGenesis’s cell therapies are engrafted using endoscopic ultrasound procedure, which is associated with decreased medical risks and costs relative to full organ transplantation. Our pipeline of therapies target a variety of unmet needs, including end stage liver disease, Type 1 diabetes, end stage renal disease, aging, and autoimmune disorder.

Press Releases News Insights

Featured News

Mini liver will grow in person’s own lymph node in bold new trial

Biotechnology firm LyGenesis has injected donor cells into a person with liver failure for the first time.

This Bag of Cells Could Grow New Livers Inside of People

April 3, 2024 - April 2, 2024 - Donor livers are in short supply for transplants. A startup is attempting to grow new ones in people instead.

Here's Why 2 Pittsburgh Biotechs Inked a Research Partnership

April 11, 2023 - Two Pittsburgh biotech startups have formed a research partnership with the aim of finding new ways of treating diseases, focusing on Type 1 Diabetes.

Imagine Pharma and LyGenesis ink a research partnership / research collaboration focusing on cell therapies for Type 1 diabetes

Scientist Look to Grow 'Mini Livers' for Patients with Organ Damage

November 14, 2022 - After decades of overblown expectation, regenerative medicine looks ready to take a step further

From left to right - Michael Hufford (CEO), Eric Lagasse (CSO), and Paulo Fontes (CMO). The team says growing of ectopic organs will help patients live longer. Photo: LyGenesis

Jim Mellon: Longevity could be the best investment you ever make

October 25, 2022 - Juvenescence Chairman explains why investing in longevity has the potential to deliver significant financial, personal and humanitarian returns.

Jim Mellon: Longevity could be the best investment you ever make

The cutting-edge cellular therapies aiming to ease America's organ shortage

October 21, 2022 - Major transplantation surgeries could one day become outpatient procedures.

The cutting-edge cellular therapies aiming to ease America's organ shortage: Major transplantation surgeries could one day become outpatient procedures.

Dr. Eric Lagasse to Receive 2022 Innovation Award from the Carnegie Science Center

October 4, 2022 - On October 13, 2022, the CSC during their first-ever Geek Out Gala will present to McGowan Institute for Regenerative Medicine faculty member Eric Lagasse, PharmD, PhD, its 2022 Innovation Award.

Eric Lagasse, PharmD, PhD, is the Carnegie Science Center 2022 Innovation Award Recipient